<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; ZMH</title>
	<atom:link href="http://www.stockbloghub.com/tag/zmh/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(MDT) MedTech Industry Stock Outlook &#8211; March 2012 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611</link>
		<comments>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611#comments</comments>
		<pubDate>Tue, 20 Mar 2012 02:13:00 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94611</guid>
		<description><![CDATA[Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The difficult macroeconomic backdrop, pricing headwinds, austerity measures, reimbursement pressure, a still unstable job market and the impact of health care reform continue to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. With fewer patients going under the knife accompanied by concerns of overuse of devices, companies in the cardiovascular and orthopedic domain continue to grapple with tepid utilization. After having a buoyant first half, the MedTech sector went through a rough patch in the back half of 2011 given the weakened sector fundamentals, sluggish key end-markets ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) MedTech Industry Stock Outlook &#8211; March 2012 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609</link>
		<comments>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609#comments</comments>
		<pubDate>Thu, 08 Mar 2012 19:28:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94609</guid>
		<description><![CDATA[Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The difficult macroeconomic backdrop, pricing headwinds, austerity measures, reimbursement pressure, a still unstable job market and the impact of health care reform continue to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. With fewer patients going under the knife accompanied by concerns of overuse of devices, companies in the cardiovascular and orthopedic domain continue to grapple with tepid utilization. After having a buoyant first half, the MedTech sector went through a rough patch in the back half of 2011 given the weakened sector fundamentals, sluggish key end-markets ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZMH) Zimmer Holdings Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2012/02/06/zmh-zimmer-holdings-earnings-scorecard/91349</link>
		<comments>http://www.stockbloghub.com/2012/02/06/zmh-zimmer-holdings-earnings-scorecard/91349#comments</comments>
		<pubDate>Mon, 06 Feb 2012 20:32:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[PowerShares Dynamic Semiconductors]]></category>
		<category><![CDATA[PSI]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=91349</guid>
		<description><![CDATA[The announcement of Zimmer Holdings’ (ZMH) fourth quarter and fiscal 2011 results as on January 26, 2012, has led analysts to revise their estimates lower for the first quarter of fiscal 2012. The scenario, however, improves for the second half and onwards. Previous Quarter Highlights Zimmer reported an adjusted EPS of $1.36 during the fourth quarter of fiscal 2011, up 7.1% year over year and a couple of cents ahead of the Zacks Consensus Estimate. During the reported quarter, the company recorded $108.0 million provision for claims related to the Durom Acetabular component, which has been taken into account in the adjusted figure. For the full year, the adjusted EPS increased 10.9% to $4.80, surpassing the Zacks Consensus Estimate of $4.78. Revenues were $1.17 billion, up 2.9% on a reported basis ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/02/06/zmh-zimmer-holdings-earnings-scorecard/91349/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Technology Industry Stock Outlook &#8211; November 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069</link>
		<comments>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069#comments</comments>
		<pubDate>Fri, 18 Nov 2011 18:52:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[THOR]]></category>
		<category><![CDATA[Thoratec Corporation]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87069</guid>
		<description><![CDATA[The performance of incumbent players in the MedTech industry continued to be hamstrung by a spate of macro issues (including sustained price and procedure volume pressures) in the September quarter. The prevailing macroeconomic factors, pricing headwinds, austerity measures, reimbursement pressure and the impact of health care reform continues to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. The beleaguered U.S. implantable defibrillator market continues to bother cardiac devices makers, as reflected by sustained implant volume pressure. On the other hand, companies in the orthopedic domain remain affected by a still choppy reconstructive implant market as they faced sustained pressure across hip, knee and spine businesses in the third quarter (albeit to a lesser extent vis-à-vis the sequentially prior quarter). Although a number of these issues are ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Gets a New CEO</title>
		<link>http://www.stockbloghub.com/2011/09/21/wmgi-wright-medical-group-gets-a-new-ceo/83685</link>
		<comments>http://www.stockbloghub.com/2011/09/21/wmgi-wright-medical-group-gets-a-new-ceo/83685#comments</comments>
		<pubDate>Wed, 21 Sep 2011 15:09:26 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ACL]]></category>
		<category><![CDATA[Alcon Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83685</guid>
		<description><![CDATA[International orthopedic devices company Wright Medical Group (WMGI) recently reported that its Board of Directors chose Mr. Robert J. Palmisano as President and CEO, starting from September 17, 2011. Mr. David D. Stevens, who was interim President and CEO, will remain Chairman of the Board. Mr. Palmisano has notable expertise managing important listed medtech companies. Until recently, he was President and CEO of ev3. During his 2-year stint there, the market capitalization of ev3 jumped more than three fold, from about $800 million in April 2008 to $2,600 million in July 2010. Mr. Palmisano was President and CEO of IntraLase Corp. prior to joining ev3. Still earlier, he was President and CEO of MacroChem Corporation. He also served as President and CEO of Summit Technology Inc. until it was taken ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/21/wmgi-wright-medical-group-gets-a-new-ceo/83685/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group to Restructure</title>
		<link>http://www.stockbloghub.com/2011/09/20/wmgi-wright-medical-group-to-restructure/83539</link>
		<comments>http://www.stockbloghub.com/2011/09/20/wmgi-wright-medical-group-to-restructure/83539#comments</comments>
		<pubDate>Tue, 20 Sep 2011 19:47:35 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83539</guid>
		<description><![CDATA[International orthopedic devices company  Wright Medical Group (WMGI) recently reported that it is exercising a cost restructuring initiative to improve profitability, promote growth and strengthen cash flow, leading to enhanced shareholder value. The company believes that the early phase of this project will be concluded over the upcoming 9 months to be followed by more efficiency drives from 2012 onwards. According to Wright Medical Group, the restructuring initiative will lead to a more cost efficient enterprise, which will boost earnings in 2012. Furthermore, with a robust balance sheet, the company is well positioned to engage in further acquisitions. As per the plan, Wright Medical Group has launched several measures to curtail expenditure, including cutting down the range of its overseas product offering, streamlining its R&#38;D efforts and fine tuning factory ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/20/wmgi-wright-medical-group-to-restructure/83539/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Outlook &#8211; Sept. 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743</link>
		<comments>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743#comments</comments>
		<pubDate>Thu, 08 Sep 2011 19:53:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82743</guid>
		<description><![CDATA[June quarter results mostly mirror the preceding quarter as a host of macro headwinds (including price and procedure volume pressures) continued to haunt the MedTech industry and weighed on the performance of the incumbent players. Although a number of these issues are expected to linger over the second-half of 2011, the industry is expected to fare relatively better this year thanks to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest market, with estimated sales of roughly $95 billion in 2010. The highly-regulated medical devices industry is divided into different segments including Cardiology, Oncology, Neuro, Orthopedic and Aesthetic Devices. The U.S. medical devices ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Meets The Strret But Costs Hurt</title>
		<link>http://www.stockbloghub.com/2011/08/08/syk-stryker-meets-the-strret-but-costs-hurt/79498</link>
		<comments>http://www.stockbloghub.com/2011/08/08/syk-stryker-meets-the-strret-but-costs-hurt/79498#comments</comments>
		<pubDate>Mon, 08 Aug 2011 17:40:03 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79498</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) posted second-quarter fiscal 2011 adjusted earnings per share of 90 cents, meeting the Zacks Consensus Estimate while transcending the year-agoearnings of 80 cents. Adjusted net income jumped 10.4% year over year to $352 million. The adjusted earnings exclude $43 million in charges associated with the company’s recent buyout of its rival Orthovita and the $1.5 billion acquisition of Boston Scientific’s (BSX) Neurovascular business. However, profit (as reported) skid 3.1% to $309 million (or 79 cents a share) on account of the sizable acquisition-related charges. Stryker is on an acquisition binge to spur growth as its faces sustained pricing and procedure volume pressure in its core replacement hips and knees businesses. However, costs associated with such transactionshave weighed on its bottom line. The Kalamazoo, Michigan-based ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/08/syk-stryker-meets-the-strret-but-costs-hurt/79498/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SNN) Smith &amp; Nephew Acquires Tenet</title>
		<link>http://www.stockbloghub.com/2011/06/26/snn-smith-nephew-acquires-tenet/77396</link>
		<comments>http://www.stockbloghub.com/2011/06/26/snn-smith-nephew-acquires-tenet/77396#comments</comments>
		<pubDate>Sun, 26 Jun 2011 17:28:27 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77396</guid>
		<description><![CDATA[Smith &#38; Nephew (SNN), an international medical device major operating in the orthopedic reconstruction and trauma, endoscopy and advanced wound management market, recently announced its intention of acquiring privately-held Tenet Medical Engineering, Inc. However, the financial terms of the agreement are yet to be disclosed. Alberta-based Tenet provides advanced technology in the arthroscopic surgery space with intuitive patient positioning controls, increased versatility, adjustability and stability, global compatibility and fully integrated systems. Smith &#38; Nephew seeks to integrate Tenet’s arthroscopy portfolio with its existing products in this segment and will be sold through the company’s global sales team of Endoscopy. Prior to the acquisition, Smith &#38; Nephew had a long-standing distribution agreement with Tenet for its patient positioning products. The Endoscopy business of Smith &#38; Nephew develops and commercializes endoscopic (minimally ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/26/snn-smith-nephew-acquires-tenet/77396/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Outlook &#8211; June 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179</link>
		<comments>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179#comments</comments>
		<pubDate>Thu, 23 Jun 2011 01:09:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[Sprint Nextel Corporation]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77179</guid>
		<description><![CDATA[A host of macro headwinds (including price and procedure volume pressure) which hit the MedTech industry last year continued to haunt the sector during the March quarter and encumber growth. Although a number of these issues are expected to linger through the remainder of 2011, the industry is expected to fare relatively better this year thanks to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest market, with estimated sales of roughly $95 billion in 2010. The medical devices industry is divided into different segments including Cardiology, Oncology, Neuro, Orthopedic and Aesthetic Devices. The U.S. medical devices industry continues to grow at a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Beats Expectations &#8211; Swings to Black</title>
		<link>http://www.stockbloghub.com/2011/05/11/wmgi-wright-medical-group-beats-expectations-swings-to-black/73736</link>
		<comments>http://www.stockbloghub.com/2011/05/11/wmgi-wright-medical-group-beats-expectations-swings-to-black/73736#comments</comments>
		<pubDate>Thu, 12 May 2011 00:51:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[KCI]]></category>
		<category><![CDATA[Kinetic Concepts Inc]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73736</guid>
		<description><![CDATA[Orthopedic devices maker, Wright Medical Group (WMGI) reported first-quarter fiscal 2011 (excluding one-time items other than stock-based compensation expense) earnings per share of 19 cents, narrowly beating the Zacks Consensus Estimate of 18 cents while exceeding the year-ago earnings of 16 cents. The company swung to profit in the quarter owing to higher sales and lower costs. It has posted a net income of $3.6 million (or 9 cents per share) in the reported quarter versus a net loss of $0.5 million (or 1 cent per share) a year-ago. Net loss for the first quarter of 2010 included the after-tax effect of about $8.1 million of expenses related to U.S. government inquiries. Revenues Net sales for the quarter were $135.4 million, up 3% year over year in reported terms (2% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/11/wmgi-wright-medical-group-beats-expectations-swings-to-black/73736/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker 2011 First Quarter Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2011/05/02/syk-stryker-2011-first-quarter-earnings-scorecard/72878</link>
		<comments>http://www.stockbloghub.com/2011/05/02/syk-stryker-2011-first-quarter-earnings-scorecard/72878#comments</comments>
		<pubDate>Mon, 02 May 2011 14:53:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=72878</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) reported first-quarter fiscal 2011 adjusted (excluding one-time acquisition-related charges) earnings per share of 90 cents, beating the Zacks Consensus Estimate by a penny. The Quarter Revisited Profit (as reported) for the quarter slid 4.4% on account of a hefty charge associated with the company’s acquisition of Boston Scientific’s (BSX) neurovascular business. Revenues surged 12% year over year to $2.02 billion, ahead of the Zacks Consensus Estimate of $2 billion. Sales were boosted by sustained double-digit growth at the company’s surgical equipment unit (MedSurg) coupled with the acquisition of the neurovascular business, which offset the lingering softness in its reconstructive business. Revenues from the reconstructive business edged up 1.9% in the quarter. Stryker’s hips and trauma businesses posted growth in the quarter, partly offset by ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/02/syk-stryker-2011-first-quarter-earnings-scorecard/72878/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker First Quarter 2011 Earnings Preview</title>
		<link>http://www.stockbloghub.com/2011/04/19/syk-stryker-first-quarter-2011-earnings-preview/71773</link>
		<comments>http://www.stockbloghub.com/2011/04/19/syk-stryker-first-quarter-2011-earnings-preview/71773#comments</comments>
		<pubDate>Tue, 19 Apr 2011 19:30:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71773</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) is expected to release its first-quarter fiscal 2011 results on Tuesday, April 19, after the closing bell. Although the Michigan-based company has not divulged any specific financial targets for the quarter, it expects foreign currency to favorably impact sales by roughly 0% to 1%. The current Zacks Consensus Estimate for first quarter is 89 cents, representing an estimated 11.55% year over year growth. With respect to earnings surprise, Stryker has posted three positive surprises in the preceding four quarters while it met the Zacks Consensus Estimate on one occasion. The company has produced an average positive earnings surprise of 3.26% over the last four quarters, implying that it has beaten the Zacks Consensus Estimate by that measure. Fourth-Quarter Revisited Stryker reported better-than-expected fourth-quarter fiscal ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/19/syk-stryker-first-quarter-2011-earnings-preview/71773/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Industry Outlook &#8211; April 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413</link>
		<comments>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413#comments</comments>
		<pubDate>Thu, 31 Mar 2011 23:07:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[TOMO]]></category>
		<category><![CDATA[TomoTherapy Incorporated]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70413</guid>
		<description><![CDATA[Last year was challenging for medical device companies given the exigent economic conditions and an uncertain healthcare environment. The MedTech industry was hit by several macro headwinds in 2010 including price/volume and utilization pressure and a more restrictive regulatory environment. Although a number of these issues remain, the industry is expected to fare better this year due to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest medical devices market, with estimated sales of roughly $95 billion in 2010. The medical devices industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (“HCIT”). The U.S. medical ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medtronic Buys Rights to Gel Tech</title>
		<link>http://www.stockbloghub.com/2011/03/04/mdt-medtronic-buys-rights-to-gel-tech/67771</link>
		<comments>http://www.stockbloghub.com/2011/03/04/mdt-medtronic-buys-rights-to-gel-tech/67771#comments</comments>
		<pubDate>Sat, 05 Mar 2011 00:44:36 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[ENT]]></category>
		<category><![CDATA[Enterra Energy Trust]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=67771</guid>
		<description><![CDATA[Leading medical devices player, Medtronic (MDT) has recently acquired the rights to chitosan-dextran gel technology from its developers, Adelaide Research &#38; Innovation Private Limited, Robinson Squidgel Limited and Otago Innovation Limited in order to complement its functional endoscopic sinus surgery (FESS) product portfolio. The financial terms of the deal were however not disclosed. This innovative gel technology helps control postoperative bleeding and adhesions common in sinus patients and thereby increases the probability of a successful FESS. The demand for FESS is currently on a high with 525,000 annual cases handled in the US. The incorporation of the gel technology to Medtronic’s FESS procedure would bolster the company’s surgical technology foothold and help capitalize on the growing demand for sinus surgeries. Medtronic earns revenues from seven divisions – Cardiac Rhythm Disease ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/04/mdt-medtronic-buys-rights-to-gel-tech/67771/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker&#8217;s New Hip System Approved by FDA</title>
		<link>http://www.stockbloghub.com/2011/02/15/syk-strykers-new-hip-system-approved-by-fda/66952</link>
		<comments>http://www.stockbloghub.com/2011/02/15/syk-strykers-new-hip-system-approved-by-fda/66952#comments</comments>
		<pubDate>Tue, 15 Feb 2011 14:54:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=66952</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) has secured the 510(k) approval from the U.S. Food and Drug Administration (“FDA”) for its MDM X3 (“Modular Dual Mobility”) mobile bearing hip system. The product represents an important addition to the Michigan-based company’s portfolio of next-generation hip replacement systems. The MDM X3 is Stryker’s third-generation dual mobility device designed to enable surgeons to offer the benefits of the company’s dual mobility technology to a greater patient population. The device’s launch has been based on the success of Stryker’s flagship mobile bearing product “ADM X3” hip system launched in early 2010. The ADM X3 hip system is a premium priced product and has been positioned as an alternative to Metal-on-Metal (“MOM”) hip resurfacing systems that are, based on recent studies, associated with the risk ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/15/syk-strykers-new-hip-system-approved-by-fda/66952/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Earnings Inch Past Estimates</title>
		<link>http://www.stockbloghub.com/2011/02/14/wmgi-wright-medical-group-earnings-inch-past-estimates/66834</link>
		<comments>http://www.stockbloghub.com/2011/02/14/wmgi-wright-medical-group-earnings-inch-past-estimates/66834#comments</comments>
		<pubDate>Mon, 14 Feb 2011 20:28:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[KCI]]></category>
		<category><![CDATA[Kinetic Concepts Inc]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=66834</guid>
		<description><![CDATA[Orthopedic devices maker, Wright Medical Group (WMGI) reported fourth-quarter and fiscal 2010 adjusted (excluding one-time items) earnings per share of 22 cents and 68 cents, narrowly beating the Zacks Consensus Estimates of 21 cents and 66 cents, respectively. Reported net income shot up nearly four-fold year over year to $8.9 million (or 22 cents per share) in the reported quarter. The improvement occurred in the absence of certain write-downs and write-offs from the prior-period quarter. Revenues Net sales for the quarter were $138.3 million, up 6% year over year in reported terms (7% on a constant currency basis), beating the Zacks Consensus Estimate of $130 million.  Revenues were $519 million for fiscal 2010, up 6.5% in reported terms (6% in constant currency), also surpassing the Zacks Consensus Estimate of $511 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/14/wmgi-wright-medical-group-earnings-inch-past-estimates/66834/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Completes divestiture of OP-1 product franchise</title>
		<link>http://www.stockbloghub.com/2011/02/08/syk-stryker-completes-divestiture-of-op-1-product-franchise/66602</link>
		<comments>http://www.stockbloghub.com/2011/02/08/syk-stryker-completes-divestiture-of-op-1-product-franchise/66602#comments</comments>
		<pubDate>Wed, 09 Feb 2011 01:28:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=66602</guid>
		<description><![CDATA[Stryker Corp (SYK) has completed the divestiture of its bone growth product franchise (the “OP-1” product line) to Tokyo-based optical, medical and communication equipment maker Olympus Corporation for $60 million. The transaction includes the Michigan-based company’s manufacturing plant in Lebanon, New Hampshire. Stryker forged a definitive agreement to jettison these assets in December 2010. The OP-1 product line includes OP-1 Implant and OP-1 Putty for use in orthopedic bone applications such as lumbar spine fusion and the treatment of long bone fractures. The active ingredient in these products is the OP-1 bone growth factor that induces the formation of new bone when implanted into a bone. OP-1 products (Implant and Putty) are currently approved in the U.S. under the Humanitarian Device Exemption (“HDE”) having provided treatment to roughly 40,000 patients ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/08/syk-stryker-completes-divestiture-of-op-1-product-franchise/66602/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Fourht Quarter Earnings Beat &#8211; Concerns Linger</title>
		<link>http://www.stockbloghub.com/2011/01/26/syk-stryker-fourht-quarter-earnings-beat-concerns-linger/65798</link>
		<comments>http://www.stockbloghub.com/2011/01/26/syk-stryker-fourht-quarter-earnings-beat-concerns-linger/65798#comments</comments>
		<pubDate>Thu, 27 Jan 2011 05:29:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=65798</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted earnings per share of 93 cents exceeding the Zacks Consensus Estimate of 90 cents and the year-ago earnings of 82 cents. For fiscal 2010, adjusted earnings of $3.33 per share beat the Zacks Consensus Estimate of $3.31 and was ahead of the year-ago earnings of $2.95. The results were supported by higher sales owing to strong contribution from the Michigan-based company’s surgical equipment business. The adjusted earnings exclude the charges associated with the company’s divestiture of its bone growth product franchise (the “OP-1” product line) to Tokyo-based equipment maker Olympus Corporation. Stryker recorded an impairment charge of roughly $124 million ($77 million net of tax) in the fourth quarter to reflect an anticipated loss in connection ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/26/syk-stryker-fourht-quarter-earnings-beat-concerns-linger/65798/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Increases Quarterly Dividend</title>
		<link>http://www.stockbloghub.com/2010/12/25/syk-stryker-increases-quarterly-dividend/61861</link>
		<comments>http://www.stockbloghub.com/2010/12/25/syk-stryker-increases-quarterly-dividend/61861#comments</comments>
		<pubDate>Sun, 26 Dec 2010 03:42:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=61861</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corp (SYK) has raised its quarterly dividend to 18 cents a share from 15 cents, representing a 20% hike. This lifts the annual dividend to 72 cents per share from the current payout of 60 cents and equates to a dividend yield of roughly 1.4%. The revised quarterly dividend is payable on Jan 31, 2011, to shareholders of record as on Dec 31, 2010. Moreover, the Michigan-based company’s Board has approved an additional $500 million share repurchase authorization, representing another commitment to boost shareholder returns. The repurchase will be executed from time to time based on market conditions, stock price and other factors. Stryker has bought back shares worth roughly $410 million (as of December 7) under its existing $750 million repurchase program. The dividend increase ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/25/syk-stryker-increases-quarterly-dividend/61861/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2010/12/06/wmgi-wright-medical-group-analyst-maintains-shares-at-neutral/60005</link>
		<comments>http://www.stockbloghub.com/2010/12/06/wmgi-wright-medical-group-analyst-maintains-shares-at-neutral/60005#comments</comments>
		<pubDate>Tue, 07 Dec 2010 02:44:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=60005</guid>
		<description><![CDATA[We reaffirm our Neutral recommendation on Wright Medical Group (WMGI). Both revenues and earnings for third-quarter 2010 missed the Zacks Consensus Estimates. Sales were adversely affected by a slowdown in U.S. orthopedic reconstruction, mainly, knees and hips. The prognosis is not much better, going forward, in the near term. In the recent past, the orthopedic industry faced pricing pressure and Wright Medical was no exception. The fall in domestic knee and hip sales was somewhat countered by brisk growth in sales of extremity products, Wright Medical’s fastest growing segment. Extremity products now account for a quarter of the company’s sales. Going forward, Wright Medical is expected to benefit from the expansion of its extremities sales force. We feel, revenue growth in future will be supported by new product (including internally ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/06/wmgi-wright-medical-group-analyst-maintains-shares-at-neutral/60005/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Industry Outlook December 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379</link>
		<comments>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379#comments</comments>
		<pubDate>Tue, 07 Dec 2010 01:15:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=61379</guid>
		<description><![CDATA[Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative with 2009 worldwide sales in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (“HCIT”). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, high unmet medical needs and increased incidence of lifestyle diseases (including cardiovascular diseases, diabetes, hypertension and obesity). Neuro, Orthopedic and Aesthetic represent the fastest growing categories. The aging population represents a major catalyst for demand of medical devices. The elderly population (persons 65 years and above) base in the U.S. registered 39.6 million in 2009, representing roughly 13% of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Third Quarter 2010 Outperforms &#8211; Raises View</title>
		<link>http://www.stockbloghub.com/2010/11/17/syk-stryker-third-quarter-2010-outperforms-raises-view/55948</link>
		<comments>http://www.stockbloghub.com/2010/11/17/syk-stryker-third-quarter-2010-outperforms-raises-view/55948#comments</comments>
		<pubDate>Thu, 18 Nov 2010 04:50:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=55948</guid>
		<description><![CDATA[Medical technology giant Stryker Corporation (SYK) reported strong third-quarter fiscal 2010 results with adjusted earnings per share of 80 cents beating the Zacks Consensus Estimate of 77 cents and surpassing the year-ago earnings of 69 cents. Adjusted earnings exclude one-time items such as gain on sale of the company’s orthopaedic implants manufacturing facility in France and tax adjustments. Healthy sales from the MedSurg Equipment business boosted net income, which catapulted 47.5% year-over-year to $338 million (or 85 cents a share). Adjusted net income rose 14.2% year-over-year to $317 million. The better-than-expected results coupled with the company’s upward guidance revision pushed up Stryker’s shares $2.68 (or 5.4%) to $52.75 in after-hours trading on October 19. Highlights from the Quarter Revenues Revenues grew 6.9% year-over-year to $1,768 million, ahead of the Zacks ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/17/syk-stryker-third-quarter-2010-outperforms-raises-view/55948/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SMA) Symmetry Medical Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2010/11/12/sma-symmetry-medical-maintains-shares-at-neutral/58777</link>
		<comments>http://www.stockbloghub.com/2010/11/12/sma-symmetry-medical-maintains-shares-at-neutral/58777#comments</comments>
		<pubDate>Fri, 12 Nov 2010 19:43:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=58777</guid>
		<description><![CDATA[We reiterate our Neutral rating on Symmetry Medical (SMA) following the company’s mixed third-quarter fiscal 2010 results. Earnings for the quarter missed the Zacks Consensus Estimate while profits skid 33% year over year on account of higher costs, which more than offset revenue growth. Revenues (up 5% year over year) beat the Zacks Consensus Estimate, supported by improved demand across the company’s orthopedic implants and medical devices businesses as reflected by higher customer orders. Decline in surgical equipment sales were offset by higher revenues from the orthopedic implants business. Symmetry Medical is the largest OEM provider of orthopedic implants and instruments to orthopedic devices manufacturers. The company has diversified its offerings into areas outside of orthopedics, like dental, osteobiologic and endoscopy. Symmetry Medical has created a distinct competitive niche in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/12/sma-symmetry-medical-maintains-shares-at-neutral/58777/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Earnings Scorecard &#8211; Estimate Revisions</title>
		<link>http://www.stockbloghub.com/2010/10/26/syk-stryker-earnings-scorecard-estimate-revisions/56690</link>
		<comments>http://www.stockbloghub.com/2010/10/26/syk-stryker-earnings-scorecard-estimate-revisions/56690#comments</comments>
		<pubDate>Wed, 27 Oct 2010 00:50:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=56690</guid>
		<description><![CDATA[Third Quarter Revisited Medical technology giant Stryker Corp. (SYK) posted better-than-expected third quarter results with earnings of 80 cents per share exceeding the Zacks Consensus Estimate of 77 cents while net income rocketed 47.5% year-over-year led by sustained healthy sales from the MedSurg Equipment division. Revenues grew 6.9% year-over-year to $1,768 million, also beating the Zacks Consensus Estimate of $1,749 million. Stryker’s MedSurg business continues to show resilience in a still challenging macroeconomic backdrop. However, strong growth at MedSurg was partly marred by a yet another sluggish performance by the core Orthopedic division due to weak spine and knees sales. Stryker’s domestic sales benefited from higher shipments of orthopedic implants and surgical equipment while international revenue growth was muted on account of an unfavorable foreign exchange translation effect. Stryker raised ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/26/syk-stryker-earnings-scorecard-estimate-revisions/56690/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Third Quarter 2010 Earnings Preview</title>
		<link>http://www.stockbloghub.com/2010/10/18/syk-stryker-third-quarter-2010-earnings-preview/55595</link>
		<comments>http://www.stockbloghub.com/2010/10/18/syk-stryker-third-quarter-2010-earnings-preview/55595#comments</comments>
		<pubDate>Tue, 19 Oct 2010 00:18:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Vision-Sciences Inc]]></category>
		<category><![CDATA[VSCI]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=55595</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) is slated to release its third-quarter fiscal 2010 results on Tuesday, October 19, 2010. Although the company has not released any official guidance for the third quarter, it envisages foreign currency exchange to drag net sales by 1% to 2% in the quarter. Despite concerns over its Orthopedic unit, Stryker remains confident about meeting its sales expectation for fiscal 2010. The current Zacks Consensus Estimate for third-quarter is 77 cents, representing an estimated 11.32% year-over-year growth. With respect to earnings surprise, Stryker has posted one positive surprise in the preceding four quarters while it met the Zacks Consensus Estimate on three other occasions. Second-Quarter Flashback Stryker reported second-quarter earnings per share of 80 cents matching the Zacks Consensus Estimate while surpassing the year-ago earnings ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/18/syk-stryker-third-quarter-2010-earnings-preview/55595/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) Medical Devices Industry Outlook &#8211; August 2010 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243</link>
		<comments>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243#comments</comments>
		<pubDate>Wed, 25 Aug 2010 15:14:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WisdomTree SmallCap Dividend]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=49243</guid>
		<description><![CDATA[Prelude The global medical devices industry is fairly large, intensely competitive and highly innovative with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (HCIT). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, with Neuro, Orthopedic and Aesthetic representing the fastest growing categories. With several growth constraints in the legacy markets, medical devices companies are aiming to expand into lucrative incipient markets. Expansion in the emerging markets, especially those with double-digit annual growth rates, represents one of the best potential avenues for future growth. Our focus in this write up, however, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) Medical Devices Industry Outlook &#8211; August 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231</link>
		<comments>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231#comments</comments>
		<pubDate>Tue, 24 Aug 2010 22:53:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=49231</guid>
		<description><![CDATA[Prelude The global medical devices industry is fairly large, intensely competitive and highly innovative with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (HCIT). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, with Neuro, Orthopedic and Aesthetic representing the fastest growing categories. With several growth constraints in the legacy markets, medical devices companies are aiming to expand into lucrative incipient markets. Expansion in the emerging markets, especially those with double-digit annual growth rates, represents one of the best potential avenues for future growth. Our focus in this write up, however, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SNN) Smith &amp; Nephew Earnings Beat by a Cent</title>
		<link>http://www.stockbloghub.com/2010/08/08/snn-smith-nephew-earnings-beat-by-a-cent/47094</link>
		<comments>http://www.stockbloghub.com/2010/08/08/snn-smith-nephew-earnings-beat-by-a-cent/47094#comments</comments>
		<pubDate>Mon, 09 Aug 2010 03:57:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=47094</guid>
		<description><![CDATA[Smith &#38; Nephew (SNN) reported EPADS (earning per American Depositary Share) of 86 cents in the second quarter of 2010, beating the Zacks Consensus Estimate by a penny and the year-ago quarter’s 77 cents. Smith &#38; Nephew reported a 4% year over year increase in revenue to $959 million from $926 million in the year-ago quarter, with growth witnessed across all the three segments: Endoscopy, Advanced Wound Management and Orthopaedics. However, revenues missed the Zacks Consensus estimates of $990 million. The company reported 1% year-over-year growth in Orthopaedics revenue to $535 million, driven by a 1% decline in the U.S. and an increase of 1% in Europe. Within the segment, revenue from both Reconstruction and Trauma grew by 2% year over year. However, Clinical Therapies revenue declined by 6.6% in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/08/snn-smith-nephew-earnings-beat-by-a-cent/47094/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2010/07/27/syk-stryker-earnings-scorecard/44932</link>
		<comments>http://www.stockbloghub.com/2010/07/27/syk-stryker-earnings-scorecard/44932#comments</comments>
		<pubDate>Tue, 27 Jul 2010 13:25:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=44932</guid>
		<description><![CDATA[Second Quarter Revisited Medical devices giant Stryker Corp. (SYK) produced a mixed bag in the second quarter, matching earnings expectations while missing on the revenue front. Earnings of 80 cents per share came in line with the Zacks Consensus Estimate and net income leapt 9.5% year-over-year, led by healthy growth at the MedSurg Equipment division. Revenues grew 7.6% year-over-year to $1,758 million, but trailed the Zacks Consensus Estimate of $1,767 million as higher sales from MedSurg were marred by a sluggish Orthopedic business. International revenue growth was muted by lower Orthopedic Implants shipments, discontinued product lines, termination of distributor contracts. Lower-than-expected sales hit Stryker’s shares which slipped $1.79 (or 3.49%) in after-market trading on July 20. Agreement of Analysts The overall trend in estimate revisions for fiscal 2010 is inclined ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/27/syk-stryker-earnings-scorecard/44932/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Resolves FDA Warning Letters</title>
		<link>http://www.stockbloghub.com/2010/05/21/syk-stryker-resolves-fda-warning-letters/37948</link>
		<comments>http://www.stockbloghub.com/2010/05/21/syk-stryker-resolves-fda-warning-letters/37948#comments</comments>
		<pubDate>Fri, 21 May 2010 16:19:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMF]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[iShares S&P California Municipal Bond]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=37948</guid>
		<description><![CDATA[Stryker Corporation (SYK) recently resolved two warning letters issued by the U.S. Food and Drug Administration (FDA). The FDA has given a clean certificate to Stryker after it found that the actions undertaken by the company to address issues raised in these letters were sufficient. In 2007, Stryker received a warning letter from the FDA regarding compliance issues with regard to certain quality system requirements at its reconstructive implant manufacturing facility in Cork, Ireland. In 2009, Stryker received another warning letter from the FDA related to compliance issues for one of its craniomaxillofacial (CMF) implant products. These products were sold through the company’s CMF distribution facility in Portage, Michigan. Stryker took corrective actions at both its Cork and CMF facilities. The FDA has informed Stryker that no further formal corrective ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/21/syk-stryker-resolves-fda-warning-letters/37948/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Review &#8211; May 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/05/11/mdt-medical-devices-stock-review-may-2010-industry-outlook/36750</link>
		<comments>http://www.stockbloghub.com/2010/05/11/mdt-medical-devices-stock-review-may-2010-industry-outlook/36750#comments</comments>
		<pubDate>Tue, 11 May 2010 21:55:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[OMCL]]></category>
		<category><![CDATA[Omnicell Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=36750</guid>
		<description><![CDATA[The global medical devices industry is fairly large, with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different categories such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices, Healthcare IT, etc. We recommend companies providing life-sustaining products to investors in the medical devices space. These companies provide a strong recurring stream of revenues as patients are unable to forego these products due to their life-sustaining nature. Furthermore, investors should allocate funds to companies with high-earnings-quality profiles. Large companies with a wide portfolio of products are also better poised for improved returns. These companies have a greater capability of withstanding a downturn in the economy. We advise investors to avoid companies that have grown historically through ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/11/mdt-medical-devices-stock-review-may-2010-industry-outlook/36750/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Earnings Outperform</title>
		<link>http://www.stockbloghub.com/2010/05/06/wmgi-wright-medical-group-earnings-outperform/36476</link>
		<comments>http://www.stockbloghub.com/2010/05/06/wmgi-wright-medical-group-earnings-outperform/36476#comments</comments>
		<pubDate>Thu, 06 May 2010 23:21:08 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=36476</guid>
		<description><![CDATA[Wright Medical Group, Inc. (WMGI) reported first quarter fiscal 2010 earnings per share of 21 cents, outperforming the Zacks Consensus Estimate of 15 cents and the year-ago earnings of 20 cents. Sales Total revenues in the first quarter increased 8.5% year over year to $131.2 million. Excluding a favorable foreign currency translation, net sales increased 7.0% year over year. Growth was witnessed across all major business segments. Hip, Knee, Extremity and Biologics products revenue increased 10.4%, 6.7%, 16.0%, and 0.1% year over year to $46.3 million, $32.4 million, $30.1 million and $19.8 million, respectively. Other category of revenue declined 8.7% year over year to $2.6 million. Geographically, the U.S. contributed roughly 59% to total revenues and increased 4.5% year over year. International revenues contributed the balance and increased 14.9% year ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/06/wmgi-wright-medical-group-earnings-outperform/36476/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZMH) Zimmer Holdings&#8217; Earnings Outperform by a Penny</title>
		<link>http://www.stockbloghub.com/2010/04/22/zmh-zimmer-holdings-earnings-outperform-by-a-penny/34758</link>
		<comments>http://www.stockbloghub.com/2010/04/22/zmh-zimmer-holdings-earnings-outperform-by-a-penny/34758#comments</comments>
		<pubDate>Thu, 22 Apr 2010 21:13:41 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=34758</guid>
		<description><![CDATA[Zimmer Holdings, Inc. (ZMH) reported first quarter fiscal 2010 earnings per share of $1.02, beating the Zacks Consensus Estimate of $1.01 and the year-ago earnings of 95 cents. Sales Total revenues in the first quarter increased 7.1% year over year to $1,062.8 million. Excluding a favorable foreign currency translation (FX), net sales increased 3.4% year over year. Excluding Spine, growth was witnessed across all business segments. Reconstructive revenues increased 7% year over year to $814.5 million. OSP and Trauma revenues increased 22% and 6% year over year to $76.2 million and $60.4 million, respectively. Dental revenues increased 9% year over year to $51.7 million. Spine sales declined 7% year over year to $60.0 million. On a geographic basis, the U.S. contributed 58% to total first quarter revenues and increased 4% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/22/zmh-zimmer-holdings-earnings-outperform-by-a-penny/34758/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Beats Consensus Estimate</title>
		<link>http://www.stockbloghub.com/2010/04/21/syk-stryker-beats-consensus-estimate/34480</link>
		<comments>http://www.stockbloghub.com/2010/04/21/syk-stryker-beats-consensus-estimate/34480#comments</comments>
		<pubDate>Wed, 21 Apr 2010 15:28:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=34480</guid>
		<description><![CDATA[Stryker Corporation (SYK) reported results for the first quarter of fiscal 2010. Earnings per share were 80 cents, surpassing the Zacks Consensus Estimate of 78 cents and the year-ago earnings of 71 cents. Sales Total revenues in the first quarter increased 12.4% year over year to $1,799.1 million. Excluding a favorable foreign currency translation (FX), net sales increased 8.7% year over year. Growth was witnessed across both the business segments. Orthopedic Implants sales increased 10.7% year over year to $1,076.9 million. Growth was led by strong demand for the company’s Hips, Knees, Trauma and Spine products. MedSurg Equipment sales increased 15.0% year over year to $722.2 million. Growth can be attributed to higher sales of Surgical equipment and surgical navigation systems, Endoscopic and communications systems, and Patient handling and emergency ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/21/syk-stryker-beats-consensus-estimate/34480/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Analyst Maintains Stock at Neutral</title>
		<link>http://www.stockbloghub.com/2010/04/08/syk-stryker-analyst-maintains-stock-at-neutral/33199</link>
		<comments>http://www.stockbloghub.com/2010/04/08/syk-stryker-analyst-maintains-stock-at-neutral/33199#comments</comments>
		<pubDate>Thu, 08 Apr 2010 21:15:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=33199</guid>
		<description><![CDATA[We recently assigned a ‘Neutral’ rating to Stryker Corporation (SYK) with a target price of $60 based on a P/E of 18.4x our fiscal 2010 EPS estimate of $3.26. Stryker reported fourth quarter earnings per share of 82 cents, in line with the Zacks Consensus Estimate and higher than the year-ago figure of 74 cents. For fiscal 2009, earnings per share of $2.95 surpassed the year-ago figure of $2.83. Total revenues increased 6.8% year over year to $1,834.2 million in the fourth quarter. Excluding a favorable foreign currency (FX) translation, net sales increased 2.5% year over year. In terms of business segments: Orthopedic Implants sales increased 9.7% year over year to $1,115.6 million. Growth was led by strong demand for the company’s Hips, Knees, Trauma, Spine and Craniomaxillofacial products. MedSurg ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/08/syk-stryker-analyst-maintains-stock-at-neutral/33199/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZMH) Zimmer Holdings Analyst Upgrades to Neutral</title>
		<link>http://www.stockbloghub.com/2010/03/31/zmh-zimmer-holdings-analyst-upgrades-to-neutral/32427</link>
		<comments>http://www.stockbloghub.com/2010/03/31/zmh-zimmer-holdings-analyst-upgrades-to-neutral/32427#comments</comments>
		<pubDate>Wed, 31 Mar 2010 19:27:26 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[OSG America L.P.]]></category>
		<category><![CDATA[OSP]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32427</guid>
		<description><![CDATA[We recently upped Zimmer Holdings, Inc. (ZMH) to ‘Neutral’ with a target price of $61 based on a P/E of roughly 14.3x our fiscal 2010 EPS estimate of $4.27. Our decision on upgrading the stock was based on the company’s strong fourth quarter fiscal 2009 results. Zimmer reported earnings per share of $1.12 in the fourth quarter, surpassing the Zacks Consensus Estimate of $1.08 and the year-ago earnings of $1. Total revenue in the fourth quarter increased 7.5% year over year in the reported quarter. Excluding a favorable foreign currency translation (FX), net sales increased 2.5% year over year. Excluding Spine, growth was witnessed across all business segments. Reconstructive revenues increased 9% year over year to $844.9 million. Trauma and Orthopedic Surgical Products (OSP) revenues increased 11% and 15% year ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/31/zmh-zimmer-holdings-analyst-upgrades-to-neutral/32427/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Remains Neutral</title>
		<link>http://www.stockbloghub.com/2010/03/25/wmgi-wright-medical-group-remains-neutral/31565</link>
		<comments>http://www.stockbloghub.com/2010/03/25/wmgi-wright-medical-group-remains-neutral/31565#comments</comments>
		<pubDate>Fri, 26 Mar 2010 00:58:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=31565</guid>
		<description><![CDATA[We recently reiterated our ‘Neutral’ recommendation on Wright Medical Group, Inc. (WMGI) with a target price of $17.50 based on a P/E of 25.4 our fiscal 2010 EPS estimate of 69 cents. The company’s fourth quarter and fiscal 2009 results were mixed. Wright Medical reported fourth quarter earnings per share of 23 cents, surpassing the Zacks Consensus Estimate of 19 cents. However, earnings were lower than the year-ago figure of 26 cents. For fiscal 2009, earnings per share came in at 55 cents, compared to the Zacks Consensus Estimate of 60 cents and 63 cents, a year-ago. Total revenues in the fourth quarter increased 8.0% year-over-year to $129.9 million, ahead of the company’s guidance of $122 million to $127 million. Excluding a favorable impact of foreign currency translation, net sales ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/25/wmgi-wright-medical-group-remains-neutral/31565/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Corporation Gets Good News From FDA</title>
		<link>http://www.stockbloghub.com/2010/03/25/syk-stryker-corporation-gets-good-news-from-fda/31707</link>
		<comments>http://www.stockbloghub.com/2010/03/25/syk-stryker-corporation-gets-good-news-from-fda/31707#comments</comments>
		<pubDate>Fri, 26 Mar 2010 00:30:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=31707</guid>
		<description><![CDATA[Stryker Corporation (SYK) recently received a clean bill from the U.S. Food and Drug Administration (FDA), the latter declaring that the actions undertaken by the company to address the issues raised in a 2007 warning letter are sufficient. No further formal corrective actions are required by the company. In 2007, the FDA had issued a warning letter to Stryker regarding compliance with certain quality system requirements at the company’s reconstructive implant manufacturing facility in Mahwah, New Jersey. The resolution of the warning letter indicates Stryker’s focus on improving quality systems throughout its organization. Stryker is one of the world’s largest medical devices companies operating in the global orthopedic market. In the orthopedic space, Stryker faces competition from major players like Zimmer Holdings Inc. (ZMH), CONMED Corporation (CNMD), Smith &#38; Nephew (SNN), ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/25/syk-stryker-corporation-gets-good-news-from-fda/31707/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Corporation Reports Preliminary Results</title>
		<link>http://www.stockbloghub.com/2010/01/14/syk-stryker-corporation-reports-preliminary-results/24968</link>
		<comments>http://www.stockbloghub.com/2010/01/14/syk-stryker-corporation-reports-preliminary-results/24968#comments</comments>
		<pubDate>Thu, 14 Jan 2010 19:19:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24968</guid>
		<description><![CDATA[Stryker Corporation (SYK) reported preliminary revenue results for the fourth quarter and full fiscal 2009. For the fourth quarter, net sales were $1,834 million, an increase of 6.8% year over year. Excluding a favorable foreign currency translation (FX), net sales increased 2.5% year over year. For full fiscal 2009, net sales were $6,723 million, an increase of 0.1% year over year. Excluding an unfavorable FX, net sales increased 1.7% year over year. Stryker will report full fourth quarter and fiscal 2009 results on Jan 26, 2010 after the market closes. In terms of business segments: Orthopedic Implants sales increased 9.7% year over year to $1,116 million in the fourth quarter of 2009. MedSurg Equipment sales increased 2.5% year over year to $719 million in the reported quarter. In fiscal 2009, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/14/syk-stryker-corporation-reports-preliminary-results/24968/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TSON) TranS1 Reports Preliminary Revenues</title>
		<link>http://www.stockbloghub.com/2010/01/08/tson-trans1-reports-preliminary-revenues/24515</link>
		<comments>http://www.stockbloghub.com/2010/01/08/tson-trans1-reports-preliminary-revenues/24515#comments</comments>
		<pubDate>Fri, 08 Jan 2010 20:05:02 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[TranS1 Inc]]></category>
		<category><![CDATA[TSON]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24515</guid>
		<description><![CDATA[TranS1 Inc. (TSON) has reported preliminary revenues for the fourth quarter of 2009. Revenues are expected to be approximately in the range of $6.2 million to $6.3 million, lower than the company’s previous guidance of $6.7 million to $7.2 million. The company expects to report its full fourth quarter results in late February 2010. TranS1 has lowered its guidance on revenues due to concerns in the market regarding reimbursement for its AxiaLIF procedure. The company is addressing these issues through continuous education and support resources for its current and prospective surgeon users. TranS1 is also negotiating with the Centre for Medicare and Medicaid (CMS) and different private payors to settle these issues. TranS1 is a medical device company focused on designing, developing and marketing products that use its proprietary minimally ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/08/tson-trans1-reports-preliminary-revenues/24515/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Completes Acquisition of Ascent Healthcare Solutions</title>
		<link>http://www.stockbloghub.com/2010/01/04/syk-stryker-completes-acquisition-of-ascent-healthcare-solutions/24078</link>
		<comments>http://www.stockbloghub.com/2010/01/04/syk-stryker-completes-acquisition-of-ascent-healthcare-solutions/24078#comments</comments>
		<pubDate>Mon, 04 Jan 2010 17:55:35 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24078</guid>
		<description><![CDATA[Stryker Corporation (SYK) recently completed the acquisition of Ascent Healthcare Solutions, the market leader in the reprocessing and remanufacturing of medical devices in the U.S. The acquisition will be neutral to Stryker’s earnings per share in 2010 and accretive thereafter. Post-acquisition, Ascent Healthcare Solutions has become a division of Stryker under the company’s MedSurg group of businesses and has retained its name. Ascent Healthcare Solutions Inc. was formed in 2005 by the merger of Alliance Medical Corporation and Vanguard Medical Concepts. These two were the leading players in the reprocessing and remanufacturing of medical devices. Ascent Healthcare Solutions Inc. provides its services to 1,800 leading hospitals and numerous Group Purchasing Organizations (GPOs) throughout North America. The company has two state-of-the-art reprocessing facilities in Phoenix, Arizona and Lakeland, Florida. Ascent Healthcare ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/04/syk-stryker-completes-acquisition-of-ascent-healthcare-solutions/24078/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Sees Operations Relocation Costs</title>
		<link>http://www.stockbloghub.com/2009/12/29/wmgi-wright-medical-group-sees-operations-relocation-costs/23867</link>
		<comments>http://www.stockbloghub.com/2009/12/29/wmgi-wright-medical-group-sees-operations-relocation-costs/23867#comments</comments>
		<pubDate>Wed, 30 Dec 2009 01:02:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23867</guid>
		<description><![CDATA[Wright Medical Group, Inc. (WMGI) reported that it will incur a relocation cost of as much as $4 million for relocating its French distribution and supply operations to its European headquarters in Amsterdam. The relocation plan was first announced by the company in Oct 2009. Wright expects to complete the relocation by Dec 31, 2009. Wright provided a detailed breakdown of these expenses that include: $1 million-$1.5 million for severance and other termination benefits; $1 million -$1.5 million for contract termination charges; $500,000 for external legal and professional fees; and $500,000 for other restructuring related costs. The company expects to report most of these expenses in the fourth quarter of 2009 and the rest in 2010. We think that Wright Medical will be least affected by the relocation cost. The company reported strong fiscal ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/29/wmgi-wright-medical-group-sees-operations-relocation-costs/23867/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker&#8217;s Announces New Share Repurchases</title>
		<link>http://www.stockbloghub.com/2009/12/10/syk-strykers-announces-new-share-repurchases/22510</link>
		<comments>http://www.stockbloghub.com/2009/12/10/syk-strykers-announces-new-share-repurchases/22510#comments</comments>
		<pubDate>Thu, 10 Dec 2009 21:19:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22510</guid>
		<description><![CDATA[Stryker Corp. (SYK) recently announced that share repurchases of up to $750 million has been authorized by its Board of Directors. The manner, timing and amount of any purchases will depend on market conditions, stock price and other factors and will be subject to regulatory considerations. Share repurchases can be made from the open market and in privately negotiated transactions. Stryker had a strong cash, cash equivalents and short-term investments of roughly $2.9 billion at the end of the third quarter of 2009. The company may make use of this cash for repurchases of shares. Stryker had 397.7 million shares outstanding as of Oct 31, 2009. Stryker’s Board of Directors also declared a quarterly dividend of 15 cents per share. The dividend is payable on Jan 29, 2010 to shareholders ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/10/syk-strykers-announces-new-share-repurchases/22510/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Earns Favorable Judgement in Patent Case</title>
		<link>http://www.stockbloghub.com/2009/12/02/wmgi-wright-medical-group-earns-favorable-judgement-in-patent-case/21742</link>
		<comments>http://www.stockbloghub.com/2009/12/02/wmgi-wright-medical-group-earns-favorable-judgement-in-patent-case/21742#comments</comments>
		<pubDate>Wed, 02 Dec 2009 20:25:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21742</guid>
		<description><![CDATA[Wright Medical Group, Inc. (WMGI) recently received a favorable summary judgment in its patent infringement case against Howmedica Osteonics Corp., a subsidiary of Stryker Corp. (SYK). The lawsuit was filed in 2000, which alleged Wright Medical’s Advance knee implant product to have violated a patent held by Howmedica. This prompted Howmedica to seek an order of infringement and unspecified damages from Wright Medical. The U.S. District Court for the District of New Jersey invalidated Howmedica’s patent in its recent ruling on Nov 24, 2009. Stryker can file another appeal in court, failing which the case will conclude. The favorable outcome of the lawsuit eliminates substantial charges that Wright Medical might have incurred. This prevents erosion of the company’s bottom-line. Wright Medical reported strong fiscal third quarter results. Earnings per share ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/02/wmgi-wright-medical-group-earns-favorable-judgement-in-patent-case/21742/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>($SYK) Stryker Corporation Set for Acquisition</title>
		<link>http://www.stockbloghub.com/2009/12/01/syk-stryker-corporation-set-for-acquisition/21642</link>
		<comments>http://www.stockbloghub.com/2009/12/01/syk-stryker-corporation-set-for-acquisition/21642#comments</comments>
		<pubDate>Tue, 01 Dec 2009 23:44:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21642</guid>
		<description><![CDATA[Stryker Corporation (SYK) is set to acquire privately-held Ascent Healthcare Solutions Inc., the market leader in the reprocessing and remanufacturing of medical devices in the U.S. The all-cash transaction is valued at $525 million. The acquisition is expected to close by the end of 2009. It will be neutral to Stryker&#8217;s earnings per share in 2010 and accretive thereafter. Post-acquisition, Ascent Healthcare Solutions will become a division of Stryker under the company’s MedSurg group of businesses and will retain its name. Ascent Healthcare Solutions Inc. was formed in 2005 by the merger of Alliance Medical Corporation and Vanguard Medical Concepts. These two were the leading players in the reprocessing and remanufacturing of medical devices. Ascent Healthcare Solutions Inc. presently provides its services to 1,800 leading hospitals and numerous Group Purchasing ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/01/syk-stryker-corporation-set-for-acquisition/21642/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Corporation Strikes Acquisition Deals</title>
		<link>http://www.stockbloghub.com/2009/11/14/syk-stryker-corporation-strikes-acquisition-deals/20474</link>
		<comments>http://www.stockbloghub.com/2009/11/14/syk-stryker-corporation-strikes-acquisition-deals/20474#comments</comments>
		<pubDate>Sat, 14 Nov 2009 22:45:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SURG]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Synergetics USA Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20474</guid>
		<description><![CDATA[Stryker Corp. (SYK) is on a takeover spree having made three acquisitions recently. The company acquired OtisMed Corp., Mutoh Co. Ltd. and certain of its affiliates, and Synergetics USA, Inc. (SURG). Financial terms of these transactions include $67 million in upfront payment as well as potential future milestone and royalty payments of up to $36 million. These acquisitions are expected to be completed by the end of 2009. OtisMed Corp. is a privately held software technology firm that focuses on customizable instrumentation complementing Stryker’s Triathlon Knee System, as well as other Stryker implants. Stryker will incorporate OtisMed as part of its Orthopaedics division. Mutoh Co. Ltd. is a Japanese company and a leading provider of equipment, products, instruments and services to the medical and scientific communities. On the other hand, Synergetics USA, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/14/syk-stryker-corporation-strikes-acquisition-deals/20474/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZMH) Zimmer Holdings to Sell Notes in Public Offering</title>
		<link>http://www.stockbloghub.com/2009/11/14/zmh-zimmer-holdings-to-sell-notes-in-public-offering/20530</link>
		<comments>http://www.stockbloghub.com/2009/11/14/zmh-zimmer-holdings-to-sell-notes-in-public-offering/20530#comments</comments>
		<pubDate>Sat, 14 Nov 2009 22:19:14 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20530</guid>
		<description><![CDATA[Zimmer Holdings, Inc. (ZMH) recently decided to raise $1 billion by selling its senior unsecured notes in an underwritten public offering in two separate transactions. The transactions involve selling $500.0 million of 4.625% notes due 2019 and $500.0 million of 5.75% notes due 2039. The public offering is expected to close on Nov 17, 2009. Zimmer has already filed an automatic shelf registration statement on Form S-3 with the Securities and Exchange Commission for the public offer. Citigroup Global Markets Inc., a division of Citigroup, Inc. (C); Banc of America Securities LLC, a division of Bank of America Corp. (BAC); and J.P. Morgan Securities Inc., a division of JPMorgan Chase &#38; Co. (JPM) are the active joint book-running managers of the offering. The offer will be made to the public ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/14/zmh-zimmer-holdings-to-sell-notes-in-public-offering/20530/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Receives FDA Approval</title>
		<link>http://www.stockbloghub.com/2009/11/11/wmgi-wright-medical-group-receives-fda-approval/20297</link>
		<comments>http://www.stockbloghub.com/2009/11/11/wmgi-wright-medical-group-receives-fda-approval/20297#comments</comments>
		<pubDate>Wed, 11 Nov 2009 20:30:42 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[PMA]]></category>
		<category><![CDATA[PowerShares Active Mega Cap]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20297</guid>
		<description><![CDATA[Wright Medical Group, Inc. (WMGI) recently received the Food and Drug administration (FDA) approval to market its CONSERVE Plus Total Hip Resurfacing System in the U.S. The new system, which has received FDA approval, provides surgeons with a bone-conserving alternative to traditional total hip replacement. With the FDA approval, Wright Medical can now market CONSERVE Plus in the original femoral and acetabular component configuration in the U.S. as specified in its PreMarket Approval (PMA) application with the FDA. The company also intends to develop additional enhancements to the system. Wright Medical is already marketing its CONSERVE Plus system, which has received FDA approval, with additional features in the international markets. The CONSERVE Plus system, which has received FDA approval, offers pain relief and restoration of normal hip functions while retaining  maximum ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/11/wmgi-wright-medical-group-receives-fda-approval/20297/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WMGI) Wright Medical Group Eclipses Consensus Estimates</title>
		<link>http://www.stockbloghub.com/2009/11/01/wmgi-wright-medical-group-eclipses-consensus-estimates/19289</link>
		<comments>http://www.stockbloghub.com/2009/11/01/wmgi-wright-medical-group-eclipses-consensus-estimates/19289#comments</comments>
		<pubDate>Sun, 01 Nov 2009 21:21:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19289</guid>
		<description><![CDATA[Wright Medical Group, Inc. (WMGI) reported third-quarter earnings per share of 19 cents, surpassing the Zacks Consensus Estimate of 9 cents. The company had earned 19 cents per share in the year-ago quarter. Sales Net sales in the reported quarter increased 6% year over year to $117.7 million. Growth was fueled by strong demand for the company’s extremity, hip and knee products that increased 18%, 7%, and 5% year over year, respectively. This was partly offset by lower biologics sales that declined 4% year over year. On a geographic basis, the U.S. contributed approximately 63% to total revenues and increased 4% year over year. International sales increased 9% year over year. Margins Gross margin declined 170 basis points (bps) year over year to 69.5% due to higher cost of goods ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/01/wmgi-wright-medical-group-eclipses-consensus-estimates/19289/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

